AHCC(®) Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus Infections

OBJECTIVE: To determine the efficacy, safety, and durability of the use of AHCC supplementation for 6 months to support the host immune system to clear high-risk human papillomavirus (HPV) infections. The AHCC supplement is a proprietary, standardized extract of cultured lentinula edodes mycelia (AH...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Judith A., Gaikwad, Anjali A., Mathew, Lata, Rech, Barbara, Faro, Jonathan P., Lucci, Joseph A., Bai, Yu, Olsen, Randall J., Byrd, Teresa T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256908/
https://www.ncbi.nlm.nih.gov/pubmed/35814366
http://dx.doi.org/10.3389/fonc.2022.881902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256908/
https://www.ncbi.nlm.nih.gov/pubmed/35814366
http://dx.doi.org/10.3389/fonc.2022.881902

Ejemplares similares